The role of FGF/FGFR signaling in promoting glycolysis has been reported in other cancers (Ye et al. 2024; Yu et al. 2017), whereas our finding emphasize that CAF-derived FGFs can promote glycolysis in SCLC cells via FGFR1 signaling. Here, FGFR1 is linked to small cell lung carcinoma.